EUVIMEDEUVIMED entdecken
Fallbericht

Uterine fibrosarcomatous dermatofibrosarcoma protuberans (FS-DFSP) with COL1A1::PDGFB fusion and concurrent TP53/ERBB2 mutations: Case report and molecular characterization

Jinchuan Yu, Haiyan Shi, Bingjian Lu

Pathology - Research and Practice · 2025-09 · 273 · 156149

DOI: 10.1016/j.prp.2025.156149 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pathology - Research and Practice, 2025-09. Verfasst von Jinchuan Yu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Pathology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China. Electronic address: …. Hauptthemen laut MEDLINE: Dermatofibrosarcoma, Tumor Suppressor Protein p53, Uterine Neoplasms, Oncogene Proteins, Fusion. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Uterine dermatofibrosarcoma protuberans (DFSP) with COL1A1::PDGFB fusion is an exceptionally rare sarcoma, and its high-grade variant remains poorly characterized. We reported a 39-year-old Chinese woman with a high-grade uterine sarcoma exhibiting morphological features of fibrosarcomatous DFSP (FS-DFSP), including spindle cells arranged in storiform and herringbone patterns, focal myoid/epithelioid differentiation, and myxoid changes. Immunohistochemistry revealed variable CD34 expression, focal desmin/SMA positivity, and aberrant p53 overexpression. Targeted next-generation sequencing identified a COL1A1-PDGFB (C5:P2) fusion, a pathogenic TP53 (c.832 C>G; p.P278A) and ERBB2 (c.2524 G>A; p.V842I) mutation. Dual-color fluorescence in situ hybridization confirmed COL1A1-PDGFB fusion. This represented the first report of high-grade uterine DFSP with concurrent TP53 and ERBB2 mutations, expanding the molecular spectrum of this entity and suggesting potential therapeutic implications for dual PDGFR/HER2 inhibition in aggressive cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DermatofibrosarcomaTumor Suppressor Protein p53Uterine NeoplasmsOncogene Proteins, FusionErb-b2 Receptor Tyrosine KinasesSkin NeoplasmsHumansFemaleAdultCollagen Type I, alpha 1 ChainMutationBiomarkers, Tumor

Stichwörter der Autor:innen

COL1A1::PDGFB fusionHER2MutationSarcomaTP53Uterine

Substanzen

Collagen Type I, alpha 1 ChainTumor Suppressor Protein p53Oncogene Proteins, FusionErb-b2 Receptor Tyrosine KinasesBiomarkers, TumorTP53 protein, humanERBB2 protein, humanCOL1A1 protein, humanCOLIA1-PDGFB fusion protein, human

Autor:innen und Institutionen

  • Department of Surgical Pathology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China. Electronic address: yujinchuan@zju.edu.cn.
  • Department of Surgical Pathology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China. Electronic address: shihy1991@zju.edu.cn.
  • Department of Surgical Pathology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China; Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecologi…

Zitieren

APA

Yu, J., Shi, H., & Lu, B. (2025). Uterine fibrosarcomatous dermatofibrosarcoma protuberans (FS-DFSP) with COL1A1::PDGFB fusion and concurrent TP53/ERBB2 mutations: Case report and molecular characterization. Pathology - Research and Practice, 273, 156149. https://doi.org/10.1016/j.prp.2025.156149

Vancouver

Yu J, Shi H, Lu B. Uterine fibrosarcomatous dermatofibrosarcoma protuberans (FS-DFSP) with COL1A1::PDGFB fusion and concurrent TP53/ERBB2 mutations: Case report and molecular characterization. Pathology - Research and Practice. 2025;273:156149. doi:10.1016/j.prp.2025.156149

BibTeX
@article{Yu2025,
  author = {Yu, Jinchuan and Shi, Haiyan and Lu, Bingjian},
  title = {Uterine fibrosarcomatous dermatofibrosarcoma protuberans (FS-DFSP) with COL1A1::PDGFB fusion and concurrent TP53/ERBB2 mutations: Case report and molecular characterization},
  journal = {Pathology - Research and Practice},
  year = {2025},
  volume = {273},
  pages = {156149},
  doi = {10.1016/j.prp.2025.156149}
}
Kostenlos starten →